Hangzhou Jiuyuan Gene Engineering (HKG:2566) plans to repurchase up to over 10.9 million Hong Kong-listed shares for a maximum of 100 million yuan, a Tuesday Hong Kong bourse filing said.
The shares will be bought back from the open market from time to time during the period, according to the genetic engineering company.
The repurchased shares may be cancelled, held as treasury shares, or used for the share incentive scheme.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments